689 results on '"Miravitlles, Marc"'
Search Results
2. WED-135-YI Impact of metabolic alterations on liver phenotype of patients with homozygous alpha-1 antitrypsin deficiency (Pi*ZZ)
3. TOP-141 Longitudinal assessment of individuals with homozygous alpha-1 antitrypsin deficiency (Pi*ZZ genotype) provides evidence for clinical patient management
4. Motivation and confidence about physical activity in COPD patients: health benefits matter to patients.
5. N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses
6. The natural history of severe chronic obstructive pulmonary disease: The SPOCCAT study protocol
7. Global mortality and readmission rates following COPD exacerbation-related hospitalization: a meta-analysis of 65945 individual patients
8. Detection of Alpha-1 Antitrypsin Levels in Chronic Obstructive Pulmonary Disease in Respiratory Clinics in Spain: Results of the EPOCONSUL 2021 Audit
9. From treatable traits to GETomics in airway disease: moving towards clinical practice
10. Hospital and intensive care unit stay associated with body mass index affect cardiorespiratory fitness in patients with COVID-19
11. Unraveling the Enigma: Spain Takes a Pioneering Step With REPAIR in the World of Inhaled Antibiotics
12. Association between occupational exposure and chronic obstructive pulmonary disease and respiratory symptoms in the Spanish population
13. Nine controversial questions about augmentation therapy for alpha-1 antitrypsin deficiency: a viewpoint
14. Effects of a telerehabilitation program and detraining on cardiorespiratory fitness in patients with post‐COVID‐19 sequelae: A randomized controlled trial
15. Improving Outcomes of Chronic Obstructive Pulmonary Disease through the Treatment of Comorbidities: One Step Beyond
16. Reply to Figueroa-Gonçalves and de Miguel-Díez
17. Utility of the Enhanced Liver Fibrosis score as a blood biomarker of pulmonary fibrosis secondary to SARS-CoV-2 pneumonia
18. Poor sleep quality, COPD severity and survival according to CASIS and Pittsburgh questionnaires
19. Poor sleep is associated with deficits of attention in COPD patients
20. Mortality and readmission after COPD exacerbation-related hospitalization: an individual patient data meta-analysis
21. Alpha-1 antitrypsin Pi*SS genotype and risk of pulmonary disease. An EARCO Research project
22. Impact of duration of inhaled antibiotic treatment in COPD patients with chronic bronchial infection by Pseudomonas
23. Identification of disease modifier genetic variants in PiZZ patients with alpha-1 antitrypsin deficiency
24. Enhanced liver fibrosis (ELF) test as a biomarker of pulmonary fibrosis (PF) secondary to COVID-19 pneumonia.
25. Blood biomarkers in patients with Alpha-1 Antitrypsin Deficiency from the EARCO CRC Registry
26. Impact of COVID-19 on patients with PiZZ alpha1-antitrypsin deficiency: the IMCA1 study revisited.
27. Elastase inhibitory activity (EIA) in Chronic Obstructive Pulmonary Disease (COPD) and Alpha-1 Antitrypsin Deficiency (AATD)
28. Tolerance to inhaled antibiotic therapy in COPD patients and chronic bronchial infection by Pseudomonas
29. Alpha-1 antitrypsin (AAT) augmentation and the liver phenotype of adults with AAT deficiency (genotype Pi*ZZ)
30. Implementing an Evidence-Based COPD Hospital Discharge Protocol: A Narrative Review and Expert Recommendations
31. Stepping Up the Personalized Approach in COPD with Machine Learning
32. Recommendations for the Implementation of the Self-Administration of Alpha-1 Antitrypsin
33. Clinical Concepts for Triple Therapy Use in Patients with COPD: A Delphi Consensus
34. Smoking and COPD Knowledge in the General Spanish Population: A CONOCEPOC Study
35. Tobacco Patterns and Risk of Chronic Obstructive Pulmonary Disease: Results From a Cross-Sectional Study
36. Impact of alcohol consumption on the liver phenotype in alpha-1 antitrypsin deficiency
37. Updating the ATS/ERS Task Force Report on Outcomes for COPD Pharmacological Trials
38. Variations in Chronic Obstructive Pulmonary Disease Outpatient Care in Respiratory Clinics: Results From the 2021 EPOCONSUL Audit
39. Clinical approach to the diagnosis and assessment of AATD
40. Exacerbations of COPD
41. Foreword
42. The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: Initial report of EARCO
43. Estimated Worldwide Prevalence of the PI*ZZ Alpha-1 Antitrypsin Genotype in Subjects With Chronic Obstructive Pulmonary Disease
44. Trends of COPD in Spain: Changes Between Cross Sectional Surveys 1997, 2007 and 2017
45. Correction: Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry
46. Severe COVID-19 Illness and α1-Antitrypsin Deficiency: COVID-AATD Study
47. Dissociation between physical capacity and daily physical activity in COPD patients. A population-based approach
48. Exacerbations in COPD: a personalised approach to care
49. COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients
50. Stepwise management of COPD: What is next after bronchodilation?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.